Skip to main content
. 2024 Nov 13;11(4):691–700. doi: 10.1007/s40801-024-00465-8

Table 2.

SGA induced urinary retention

Case (n) No case (n) Total % ROR 95%CI
All 4653 883,051 887,704 0.52
Clozapine 8 3605 3613 0.22 0.42 0.210–0.841
Risperidone 57 4404 4461 1.28 2.47 1.902–3.218
Paliperidone 12 1721 1733 0.69 1.32 0.750–2.338
Perospirone 4 589 593 0.67 1.29 0.482–3.448
Asenapine 7 544 551 1.27 2.44 1.159–5.154
Olanzapine 43 3185 3228 1.33 2.58 1.905–3.486
Quetiapine 52 3392 3444 1.51 2.93 2.225–3.860
Aripiprazole 43 3983 4026 1.07 2.06 1.522–2.784
Blonanserin 18 1130 1148 1.57 3.03 1.901–4.833
Brexpiprazole 12 575 587 2.04 3.97 2.239–7.034
Lurasidone 21 577 598 3.51 6.93 4.482–10.727

SGA, second-generation antipsychotics; ROR, reporting odds ratio; 95%CI, 95% confidence interval